NATERA, INC. Marketable Securities, Unrealized Gain (Loss)
NATERA, INC. (NTRA) reported Marketable Securities, Unrealized Gain (Loss) of $2.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-01.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesUnrealizedGainLoss · last filed 2023-03-01
- NATERA, INC. marketable securities, unrealized gain (loss) for the quarter ending 2022-12-31 was -$10.00K.
- NATERA, INC. marketable securities, unrealized gain (loss) for the quarter ending 2022-03-31 was $281.00K.
- NATERA, INC. marketable securities, unrealized gain (loss) for fiscal 2022 was $2.00K, a 81.82% decline from fiscal 2021.
- NATERA, INC. marketable securities, unrealized gain (loss) for fiscal 2021 was $11.00K.
| Period end | Marketable Securities, Unrealized Gain (Loss) 3 month | Marketable Securities, Unrealized Gain (Loss) 9 month | Marketable Securities, Unrealized Gain (Loss) 12 month |
|---|---|---|---|
| 2022-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $2.00K 10-K · filed 2023-03-01 | |
| 2022-09-30 | $12.00K 10-Q · filed 2022-11-09 | ||
| 2022-03-31 | $281.00K 10-Q · filed 2022-05-06 | ||
| 2021-12-31 | $11.00K 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |